nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolmetin—SLC22A6—Furosemide—dilated cardiomyopathy	0.315	1	CbGbCtD
Tolmetin—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A5—dilated cardiomyopathy	0.0199	0.0693	CbGpPWpGaD
Tolmetin—CXCL8—Syndecan-3-mediated signaling events—PSEN1—dilated cardiomyopathy	0.0158	0.0547	CbGpPWpGaD
Tolmetin—Toxic epidermal necrolysis—Spironolactone—dilated cardiomyopathy	0.0133	0.034	CcSEcCtD
Tolmetin—Gastritis—Spironolactone—dilated cardiomyopathy	0.0131	0.0334	CcSEcCtD
Tolmetin—Drowsiness—Spironolactone—dilated cardiomyopathy	0.0114	0.0291	CcSEcCtD
Tolmetin—Renal failure—Spironolactone—dilated cardiomyopathy	0.0112	0.0286	CcSEcCtD
Tolmetin—TDO2—Monoamine Transport—AGT—dilated cardiomyopathy	0.0107	0.0371	CbGpPWpGaD
Tolmetin—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.0106	0.0272	CcSEcCtD
Tolmetin—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.00967	0.0247	CcSEcCtD
Tolmetin—CXCL8—Unfolded Protein Response (UPR)—ZBTB17—dilated cardiomyopathy	0.00946	0.0329	CbGpPWpGaD
Tolmetin—Proteinuria—Lisinopril—dilated cardiomyopathy	0.00946	0.0242	CcSEcCtD
Tolmetin—Protein urine present—Lisinopril—dilated cardiomyopathy	0.00933	0.0238	CcSEcCtD
Tolmetin—Vascular purpura—Furosemide—dilated cardiomyopathy	0.00899	0.023	CcSEcCtD
Tolmetin—Haemolytic anaemia—Furosemide—dilated cardiomyopathy	0.00891	0.0228	CcSEcCtD
Tolmetin—Purpura—Furosemide—dilated cardiomyopathy	0.00834	0.0213	CcSEcCtD
Tolmetin—Anaphylactoid reaction—Furosemide—dilated cardiomyopathy	0.00831	0.0212	CcSEcCtD
Tolmetin—PTGS2—Synthesis of 15-eicosatetraenoic acid derivatives—GPX1—dilated cardiomyopathy	0.00793	0.0275	CbGpPWpGaD
Tolmetin—Blood urea increased—Lisinopril—dilated cardiomyopathy	0.00785	0.02	CcSEcCtD
Tolmetin—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00727	0.0186	CcSEcCtD
Tolmetin—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.00724	0.0185	CcSEcCtD
Tolmetin—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00711	0.0182	CcSEcCtD
Tolmetin—Haemolytic anaemia—Lisinopril—dilated cardiomyopathy	0.00668	0.0171	CcSEcCtD
Tolmetin—Somnolence—Spironolactone—dilated cardiomyopathy	0.00646	0.0165	CcSEcCtD
Tolmetin—Anaphylactoid reaction—Lisinopril—dilated cardiomyopathy	0.00623	0.0159	CcSEcCtD
Tolmetin—Drowsiness—Furosemide—dilated cardiomyopathy	0.0062	0.0158	CcSEcCtD
Tolmetin—Renal failure—Furosemide—dilated cardiomyopathy	0.00609	0.0156	CcSEcCtD
Tolmetin—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.00578	0.0148	CcSEcCtD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.00578	0.0201	CbGpPWpGaD
Tolmetin—Urticaria—Spironolactone—dilated cardiomyopathy	0.00577	0.0147	CcSEcCtD
Tolmetin—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00574	0.0147	CcSEcCtD
Tolmetin—Aminohippurate—SLC22A5—dilated cardiomyopathy	0.00551	1	CrCbGaD
Tolmetin—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.00543	0.0139	CcSEcCtD
Tolmetin—Visual impairment—Furosemide—dilated cardiomyopathy	0.00536	0.0137	CcSEcCtD
Tolmetin—Gastritis—Lisinopril—dilated cardiomyopathy	0.00534	0.0136	CcSEcCtD
Tolmetin—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.00526	0.0134	CcSEcCtD
Tolmetin—Tinnitus—Furosemide—dilated cardiomyopathy	0.00519	0.0132	CcSEcCtD
Tolmetin—CXCL8—Validated transcriptional targets of AP1 family members Fra1 and Fra2—GJA1—dilated cardiomyopathy	0.00508	0.0177	CbGpPWpGaD
Tolmetin—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00497	0.0127	CcSEcCtD
Tolmetin—CXCL8—Syndecan-2-mediated signaling events—ITGB1—dilated cardiomyopathy	0.00493	0.0171	CbGpPWpGaD
Tolmetin—CXCL8—Chemokine receptors bind chemokines—CXCL2—dilated cardiomyopathy	0.00491	0.0171	CbGpPWpGaD
Tolmetin—Dysuria—Lisinopril—dilated cardiomyopathy	0.00488	0.0125	CcSEcCtD
Tolmetin—TDO2—Monoamine Transport—TNF—dilated cardiomyopathy	0.00484	0.0168	CbGpPWpGaD
Tolmetin—Dizziness—Spironolactone—dilated cardiomyopathy	0.0048	0.0123	CcSEcCtD
Tolmetin—CXCL8—AP-1 transcription factor network—NPPA—dilated cardiomyopathy	0.00478	0.0166	CbGpPWpGaD
Tolmetin—Flatulence—Furosemide—dilated cardiomyopathy	0.00477	0.0122	CcSEcCtD
Tolmetin—Weight increased—Lisinopril—dilated cardiomyopathy	0.00475	0.0121	CcSEcCtD
Tolmetin—Weight decreased—Lisinopril—dilated cardiomyopathy	0.00472	0.0121	CcSEcCtD
Tolmetin—Vomiting—Spironolactone—dilated cardiomyopathy	0.00462	0.0118	CcSEcCtD
Tolmetin—MPO—Vitamin B12 Metabolism—SOD2—dilated cardiomyopathy	0.00462	0.016	CbGpPWpGaD
Tolmetin—Renal failure—Lisinopril—dilated cardiomyopathy	0.00457	0.0117	CcSEcCtD
Tolmetin—CXCL8—Chemokine receptors bind chemokines—CXCR3—dilated cardiomyopathy	0.00456	0.0159	CbGpPWpGaD
Tolmetin—Headache—Spironolactone—dilated cardiomyopathy	0.00455	0.0116	CcSEcCtD
Tolmetin—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.00452	0.0115	CcSEcCtD
Tolmetin—Haematuria—Lisinopril—dilated cardiomyopathy	0.00443	0.0113	CcSEcCtD
Tolmetin—Epistaxis—Lisinopril—dilated cardiomyopathy	0.00439	0.0112	CcSEcCtD
Tolmetin—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.00434	0.0111	CcSEcCtD
Tolmetin—Nausea—Spironolactone—dilated cardiomyopathy	0.00432	0.011	CcSEcCtD
Tolmetin—Hepatitis—Lisinopril—dilated cardiomyopathy	0.00417	0.0107	CcSEcCtD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.00412	0.0143	CbGpPWpGaD
Tolmetin—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—dilated cardiomyopathy	0.00399	0.0139	CbGpPWpGaD
Tolmetin—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00395	0.0101	CcSEcCtD
Tolmetin—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.00395	0.0101	CcSEcCtD
Tolmetin—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00389	0.00994	CcSEcCtD
Tolmetin—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00387	0.00988	CcSEcCtD
Tolmetin—MPO—Folate Metabolism—SOD2—dilated cardiomyopathy	0.00376	0.013	CbGpPWpGaD
Tolmetin—CXCL8—Unfolded Protein Response (UPR)—LMNA—dilated cardiomyopathy	0.00372	0.0129	CbGpPWpGaD
Tolmetin—MPO—Folate Metabolism—GPX1—dilated cardiomyopathy	0.00358	0.0124	CbGpPWpGaD
Tolmetin—Flatulence—Lisinopril—dilated cardiomyopathy	0.00358	0.00915	CcSEcCtD
Tolmetin—Somnolence—Furosemide—dilated cardiomyopathy	0.00351	0.00898	CcSEcCtD
Tolmetin—Constipation—Furosemide—dilated cardiomyopathy	0.00338	0.00863	CcSEcCtD
Tolmetin—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00323	0.00826	CcSEcCtD
Tolmetin—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FASLG—dilated cardiomyopathy	0.00322	0.0112	CbGpPWpGaD
Tolmetin—Urticaria—Furosemide—dilated cardiomyopathy	0.00314	0.00802	CcSEcCtD
Tolmetin—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00312	0.00798	CcSEcCtD
Tolmetin—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00312	0.00798	CcSEcCtD
Tolmetin—Chest pain—Lisinopril—dilated cardiomyopathy	0.00309	0.0079	CcSEcCtD
Tolmetin—CXCL8—AP-1 transcription factor network—GJA1—dilated cardiomyopathy	0.00305	0.0106	CbGpPWpGaD
Tolmetin—MPO—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	0.00298	0.0104	CbGpPWpGaD
Tolmetin—Oedema—Lisinopril—dilated cardiomyopathy	0.00297	0.00758	CcSEcCtD
Tolmetin—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00297	0.00758	CcSEcCtD
Tolmetin—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.0029	0.00742	CcSEcCtD
Tolmetin—PTGS2—S1P1 pathway—RAC1—dilated cardiomyopathy	0.00289	0.01	CbGpPWpGaD
Tolmetin—CXCL8—Allograft Rejection—AGTR1—dilated cardiomyopathy	0.00287	0.00996	CbGpPWpGaD
Tolmetin—CXCL8—Overview of nanoparticle effects—TNF—dilated cardiomyopathy	0.00286	0.00993	CbGpPWpGaD
Tolmetin—MPO—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	0.00285	0.00989	CbGpPWpGaD
Tolmetin—Asthenia—Furosemide—dilated cardiomyopathy	0.00284	0.00724	CcSEcCtD
Tolmetin—CXCL8—Syndecan-3-mediated signaling events—EGFR—dilated cardiomyopathy	0.00277	0.00963	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—CXCL2—dilated cardiomyopathy	0.0027	0.0094	CbGpPWpGaD
Tolmetin—Diarrhoea—Furosemide—dilated cardiomyopathy	0.0027	0.00691	CcSEcCtD
Tolmetin—CXCL8—AP-1 transcription factor network—IL10—dilated cardiomyopathy	0.00265	0.0092	CbGpPWpGaD
Tolmetin—Somnolence—Lisinopril—dilated cardiomyopathy	0.00264	0.00673	CcSEcCtD
Tolmetin—Dizziness—Furosemide—dilated cardiomyopathy	0.00261	0.00668	CcSEcCtD
Tolmetin—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00261	0.00667	CcSEcCtD
Tolmetin—Constipation—Lisinopril—dilated cardiomyopathy	0.00254	0.00648	CcSEcCtD
Tolmetin—Vomiting—Furosemide—dilated cardiomyopathy	0.00251	0.00642	CcSEcCtD
Tolmetin—CXCL8—LPA receptor mediated events—RAC1—dilated cardiomyopathy	0.0025	0.00868	CbGpPWpGaD
Tolmetin—Headache—Furosemide—dilated cardiomyopathy	0.00248	0.00632	CcSEcCtD
Tolmetin—CXCL8—EBV LMP1 signaling—TNF—dilated cardiomyopathy	0.00245	0.00853	CbGpPWpGaD
Tolmetin—CXCL8—Corticotropin-releasing hormone—GJA1—dilated cardiomyopathy	0.00245	0.00852	CbGpPWpGaD
Tolmetin—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00243	0.00619	CcSEcCtD
Tolmetin—CXCL8—Allograft Rejection—IL10—dilated cardiomyopathy	0.0024	0.00835	CbGpPWpGaD
Tolmetin—Urticaria—Lisinopril—dilated cardiomyopathy	0.00236	0.00602	CcSEcCtD
Tolmetin—Nausea—Furosemide—dilated cardiomyopathy	0.00235	0.006	CcSEcCtD
Tolmetin—TDO2—Metabolism—ANKRD1—dilated cardiomyopathy	0.00235	0.00815	CbGpPWpGaD
Tolmetin—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00234	0.00599	CcSEcCtD
Tolmetin—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00234	0.00599	CcSEcCtD
Tolmetin—MPO—IL23-mediated signaling events—TNF—dilated cardiomyopathy	0.00226	0.00786	CbGpPWpGaD
Tolmetin—CXCL8—Allograft Rejection—FASLG—dilated cardiomyopathy	0.00223	0.00776	CbGpPWpGaD
Tolmetin—CXCL8—AP-1 transcription factor network—AGT—dilated cardiomyopathy	0.00222	0.00772	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—TAZ—dilated cardiomyopathy	0.00221	0.00766	CbGpPWpGaD
Tolmetin—PTGS2—Calcium signaling in the CD4+ TCR pathway—FASLG—dilated cardiomyopathy	0.00218	0.00758	CbGpPWpGaD
Tolmetin—CXCL8—Allograft Rejection—FAS—dilated cardiomyopathy	0.00215	0.00748	CbGpPWpGaD
Tolmetin—Asthenia—Lisinopril—dilated cardiomyopathy	0.00213	0.00543	CcSEcCtD
Tolmetin—CXCL8—IL-3 Signaling Pathway—RAF1—dilated cardiomyopathy	0.00205	0.00713	CbGpPWpGaD
Tolmetin—CXCL8—Bladder Cancer—EGFR—dilated cardiomyopathy	0.00203	0.00705	CbGpPWpGaD
Tolmetin—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00203	0.00518	CcSEcCtD
Tolmetin—CXCL8—Spinal Cord Injury—GJA1—dilated cardiomyopathy	0.00201	0.00698	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—SDHA—dilated cardiomyopathy	0.002	0.00693	CbGpPWpGaD
Tolmetin—Dizziness—Lisinopril—dilated cardiomyopathy	0.00196	0.00501	CcSEcCtD
Tolmetin—Vomiting—Lisinopril—dilated cardiomyopathy	0.00189	0.00482	CcSEcCtD
Tolmetin—Headache—Lisinopril—dilated cardiomyopathy	0.00186	0.00475	CcSEcCtD
Tolmetin—CXCL8—Peptide ligand-binding receptors—CXCL2—dilated cardiomyopathy	0.00185	0.00642	CbGpPWpGaD
Tolmetin—CXCL8—Peptide ligand-binding receptors—AGTR2—dilated cardiomyopathy	0.00185	0.00642	CbGpPWpGaD
Tolmetin—PTGS1—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.00183	0.00636	CbGpPWpGaD
Tolmetin—SLC22A6—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.00182	0.00631	CbGpPWpGaD
Tolmetin—Nausea—Lisinopril—dilated cardiomyopathy	0.00176	0.0045	CcSEcCtD
Tolmetin—MPO—Vitamin B12 Metabolism—TNF—dilated cardiomyopathy	0.00175	0.00608	CbGpPWpGaD
Tolmetin—CXCL8—Toll-like Receptor Signaling Pathway—RAC1—dilated cardiomyopathy	0.00172	0.00598	CbGpPWpGaD
Tolmetin—CXCL8—Peptide ligand-binding receptors—CXCR3—dilated cardiomyopathy	0.00172	0.00597	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—ZBTB17—dilated cardiomyopathy	0.00167	0.00579	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—TAZ—dilated cardiomyopathy	0.00167	0.00579	CbGpPWpGaD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.00161	0.00559	CbGpPWpGaD
Tolmetin—PTGS1—Overview of nanoparticle effects—TNF—dilated cardiomyopathy	0.00158	0.00548	CbGpPWpGaD
Tolmetin—CXCL8—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.00156	0.00542	CbGpPWpGaD
Tolmetin—CXCL8—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.00156	0.00542	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—RAC1—dilated cardiomyopathy	0.00153	0.00532	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	0.00151	0.00526	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.00149	0.00519	CbGpPWpGaD
Tolmetin—PTGS2—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.00145	0.00505	CbGpPWpGaD
Tolmetin—CXCL8—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.00145	0.00503	CbGpPWpGaD
Tolmetin—MPO—Folate Metabolism—TNF—dilated cardiomyopathy	0.00142	0.00495	CbGpPWpGaD
Tolmetin—CXCL8—Peptide ligand-binding receptors—AGTR1—dilated cardiomyopathy	0.00142	0.00494	CbGpPWpGaD
Tolmetin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FASLG—dilated cardiomyopathy	0.00141	0.0049	CbGpPWpGaD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.00139	0.00484	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—RAC1—dilated cardiomyopathy	0.00134	0.00467	CbGpPWpGaD
Tolmetin—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—dilated cardiomyopathy	0.00132	0.00458	CbGpPWpGaD
Tolmetin—PTGS2—Overview of nanoparticle effects—TNF—dilated cardiomyopathy	0.00125	0.00435	CbGpPWpGaD
Tolmetin—CXCL8—Corticotropin-releasing hormone—RAF1—dilated cardiomyopathy	0.00124	0.00431	CbGpPWpGaD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00124	0.00431	CbGpPWpGaD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00124	0.00431	CbGpPWpGaD
Tolmetin—PTGS1—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	0.00122	0.00424	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—CXCL2—dilated cardiomyopathy	0.00118	0.00412	CbGpPWpGaD
Tolmetin—PTGS1—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	0.00116	0.00405	CbGpPWpGaD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00115	0.004	CbGpPWpGaD
Tolmetin—CXCL8—LPA receptor mediated events—EGFR—dilated cardiomyopathy	0.00114	0.00395	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.00113	0.00394	CbGpPWpGaD
Tolmetin—MPO—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	0.00113	0.00393	CbGpPWpGaD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00112	0.00388	CbGpPWpGaD
Tolmetin—CXCL8—Senescence and Autophagy in Cancer—RAF1—dilated cardiomyopathy	0.00112	0.00387	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.00107	0.0037	CbGpPWpGaD
Tolmetin—CXCL8—Peptide ligand-binding receptors—AGT—dilated cardiomyopathy	0.001	0.00347	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	0.000969	0.00337	CbGpPWpGaD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000953	0.00331	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000948	0.00329	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	0.000945	0.00328	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000944	0.00328	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000944	0.00328	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	0.000925	0.00321	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000922	0.0032	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000922	0.0032	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—SOD2—dilated cardiomyopathy	0.000919	0.00319	CbGpPWpGaD
Tolmetin—CXCL8—Allograft Rejection—TNF—dilated cardiomyopathy	0.000914	0.00318	CbGpPWpGaD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000904	0.00314	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000899	0.00312	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—GJA1—dilated cardiomyopathy	0.000881	0.00306	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000877	0.00305	CbGpPWpGaD
Tolmetin—CXCL8—Cellular responses to stress—GPX1—dilated cardiomyopathy	0.000876	0.00304	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000858	0.00298	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00085	0.00295	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000845	0.00294	CbGpPWpGaD
Tolmetin—CXCL8—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000843	0.00293	CbGpPWpGaD
Tolmetin—CXCL8—Toll-like Receptor Signaling Pathway—TNF—dilated cardiomyopathy	0.000745	0.00259	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000726	0.00252	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—EGFR—dilated cardiomyopathy	0.000697	0.00242	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000689	0.00239	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—RAC1—dilated cardiomyopathy	0.000671	0.00233	CbGpPWpGaD
Tolmetin—CXCL8—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000671	0.00233	CbGpPWpGaD
Tolmetin—CXCL8—Spinal Cord Injury—TNF—dilated cardiomyopathy	0.000663	0.0023	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—LMNA—dilated cardiomyopathy	0.000656	0.00228	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	0.000648	0.00225	CbGpPWpGaD
Tolmetin—PTGS2—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	0.000617	0.00215	CbGpPWpGaD
Tolmetin—CXCL8—Regulation of toll-like receptor signaling pathway—TNF—dilated cardiomyopathy	0.000582	0.00202	CbGpPWpGaD
Tolmetin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—dilated cardiomyopathy	0.000578	0.00201	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—ACE—dilated cardiomyopathy	0.000567	0.00197	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—GPX1—dilated cardiomyopathy	0.000542	0.00188	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000533	0.00185	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000533	0.00185	CbGpPWpGaD
Tolmetin—CXCL8—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.000531	0.00184	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—CD36—dilated cardiomyopathy	0.000528	0.00183	CbGpPWpGaD
Tolmetin—CXCL8—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000511	0.00177	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000504	0.00175	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000496	0.00172	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000484	0.00168	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000484	0.00168	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	0.000483	0.00168	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00048	0.00167	CbGpPWpGaD
Tolmetin—TDO2—Metabolism—AGT—dilated cardiomyopathy	0.000475	0.00165	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—TAZ—dilated cardiomyopathy	0.000474	0.00165	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	0.000466	0.00162	CbGpPWpGaD
Tolmetin—PTGS1—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	0.000463	0.00161	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	0.000456	0.00159	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00045	0.00156	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000436	0.00152	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—SDHA—dilated cardiomyopathy	0.000429	0.00149	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.00041	0.00142	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—ANKRD1—dilated cardiomyopathy	0.0004	0.00139	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000389	0.00135	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—TAZ—dilated cardiomyopathy	0.000377	0.00131	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000372	0.00129	CbGpPWpGaD
Tolmetin—PTGS2—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	0.000367	0.00128	CbGpPWpGaD
Tolmetin—CXCL8—Metabolism of proteins—AGT—dilated cardiomyopathy	0.000359	0.00125	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000353	0.00123	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—SDHA—dilated cardiomyopathy	0.000341	0.00118	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000322	0.00112	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—EGFR—dilated cardiomyopathy	0.000305	0.00106	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	0.000303	0.00105	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000302	0.00105	CbGpPWpGaD
Tolmetin—PTGS2—Spinal Cord Injury—TNF—dilated cardiomyopathy	0.000291	0.00101	CbGpPWpGaD
Tolmetin—CXCL8—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000289	0.001	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000286	0.000994	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000286	0.000994	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000274	0.000953	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000266	0.000924	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000262	0.000911	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000262	0.000909	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000258	0.000895	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000255	0.000885	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000229	0.000797	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.00022	0.000764	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000209	0.000725	CbGpPWpGaD
Tolmetin—PTGS2—Disease—NPPA—dilated cardiomyopathy	0.000208	0.000723	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000208	0.000722	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	0.000208	0.000721	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000202	0.000703	CbGpPWpGaD
Tolmetin—PTGS2—Disease—PSEN2—dilated cardiomyopathy	0.000202	0.0007	CbGpPWpGaD
Tolmetin—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	0.000198	0.000687	CbGpPWpGaD
Tolmetin—SLC22A6—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000187	0.00065	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000182	0.000633	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000182	0.000632	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000179	0.000623	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000162	0.000563	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—AGT—dilated cardiomyopathy	0.000155	0.000538	CbGpPWpGaD
Tolmetin—CXCL8—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000125	0.000433	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—GPX1—dilated cardiomyopathy	0.000117	0.000405	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—CD36—dilated cardiomyopathy	0.000113	0.000394	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000107	0.000373	CbGpPWpGaD
Tolmetin—PTGS1—Metabolism—AGT—dilated cardiomyopathy	0.000102	0.000355	CbGpPWpGaD
Tolmetin—PTGS2—Disease—RAC1—dilated cardiomyopathy	0.000101	0.000352	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—GPX1—dilated cardiomyopathy	9.25e-05	0.000321	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—CD36—dilated cardiomyopathy	9.01e-05	0.000313	CbGpPWpGaD
Tolmetin—PTGS2—Metabolism—AGT—dilated cardiomyopathy	8.11e-05	0.000282	CbGpPWpGaD
Tolmetin—CXCL8—Signaling Pathways—EGFR—dilated cardiomyopathy	7.37e-05	0.000256	CbGpPWpGaD
Tolmetin—PTGS2—Disease—RAF1—dilated cardiomyopathy	6.72e-05	0.000234	CbGpPWpGaD
Tolmetin—PTGS2—Disease—EGFR—dilated cardiomyopathy	4.61e-05	0.00016	CbGpPWpGaD
